Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs.
Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
Episodes
125 total · newest first
Press play on any episode and the show keeps running from there.
Abbott and the FDA develop digital healthcare, Roche gives us some market insight, and we look at Encoded’s approach to gene therapy. Sponsorswww.thescopemethod.com Story Referenceshttps://www.roche.com/dam/jcr:5c6df314-831e-4601-9f72-617d2…
Today on The Niche, big deals in Chinese big-pharma as BeiGene raises another $2 billion, Biogen and Moderna both release papers on crucial clinical trials, and a new cell-type could play a pivotal role in rheumatoid arthritis. Sponsorswww.…
Today on The Niche Pod, Biogen has submitted their Alzheimer’s drug aducanumab to the FDA, we take a look at the fate of PPD since their February IPO, and explore Gilead’s not-a-claim claims on their COVID-19 treatment. Sponsorswww.thescope…
Today on The Niche we will be discussing two deaths in a gene therapy trial, new COVID-19 vaccine guidelines from the FDA, and recent developments in CRISPR-Cas gene editing technologies. Story Referenceshttps://www.liebertpub.com/doi/10.10…
Interested in The Niche Podcast? Start here to learn what to expect! The Niche Podcast brings you interviews with industry experts top stories from last week in biotech, pharma, clinical research, and the life science industries. You can ex…
